Fasahar Ciwon Ƙafafun Ciwon Ciwon sukari Akwai Farko a Indiya

A KYAUTA Kyauta 1 | eTurboNews | eTN
Written by Linda Hohnholz

Alkem Laboratories Ltd. (Alkem) a nan yana sanar da ƙaddamar da fasaha na musamman da aka mallaka don maganin ciwon ƙafar ƙafar ciwon sukari (DFU) a Indiya. Maganin zai dogara ne akan fasahar 4D Bioprinting mai ruguzawa, wacce za a yi amfani da ita don kula da zurfafa, marasa warkarwa raunuka na yau da kullun kuma ana tsammanin ƙaddamar da shi a cikin kasuwar Indiya a ƙarshen rabin 2022 bayan amincewar tsari. Wannan fasaha ta ci gaba don sarrafa DFU tana da babban ikon hana yanke yanke a cikin masu ciwon sukari. Wannan fasaha za ta kasance cikin farashi mai araha ga marasa lafiya na Indiya a lokacin da babu takamaiman magani ga DFU a Indiya.

A halin yanzu Indiya tana da kusan miliyan 77 masu fama da ciwon sukari, na biyu mafi girma a duniya. Ciwon ƙafar ƙafar ciwon sukari yana ɗaya daga cikin mafi mahimmanci da rikice-rikice na ciwon sukari kuma an bayyana shi azaman ƙafar da ke fama da ciwon ciki wanda ke da alaƙa da neuropathy da / ko cututtukan jijiya na ƙananan ƙafa a cikin majiyyaci mai ciwon sukari. Aƙalla, 12-15% masu ciwon sukari suna fama da DFU aƙalla sau ɗaya a rayuwa. 5-24% daga cikinsu za su kai ga yanke gaɓoɓin hannu a cikin watanni 6-18 bayan tantancewar farko. Haɗarin ciwon ƙafa da yanke gaɓoɓin hannu yana ƙaruwa da shekaru da tsawon lokacin ciwon sukari. Alkem ya haɗa kai da Rokit Healthcare Inc. don tallata fasahar a Indiya don taimakawa rage yanke yanke tsakanin marasa lafiya na DFU idan aka yi la'akari da mummunan tasirin yanke kan ingancin rayuwar majiyyaci da kuma nauyin tattalin arziki mai alaƙa a kan tsarin kiwon lafiya.

Mista Sandeep Singh, Manajan Darakta na Alkem Laboratories Ltd., ya bayyana cewa, "A Indiya, ciwon sukari yana daya daga cikin manyan kalubalen kiwon lafiya. Kalubalen a cikin kansa yana da girma sosai wanda sau da yawa ana yin watsi da ciwon ƙafar masu ciwon sukari. Kimanin mutane 1 lac dole ne a yanke su a kowace shekara tare da yin sulhu akan ingancin rayuwarsu. Don magance matsalar, Alkem ya haɗa kai da Rokit Healthcare Inc., kamfanin samar da mafita na zamani na duniya, don fitar da sabbin hanyoyin magance cututtukan ƙafa masu ciwon sukari."

Ya kara da cewa, Mista Sandeep ya tabbatar da cewa, "Alkem, tsawon shekaru, ya kasance a kan gaba wajen bayar da kulawar majinyata mai inganci, ta hanyar kirkire-kirkire da tsare-tsare na marasa lafiya."

ABUBUWAN DA ZA KU GUDU DAGA WANNAN LABARI:

  • A diabetic foot ulcer is one of the most significant and devastating complications of diabetes and is defined as a foot affected by ulceration that is associated with neuropathy and/or peripheral arterial disease of the lower limb in a patient with diabetes.
  • to commercialize the technology in India to help reduce amputation amongst DFU patients considering the negative impact of amputation on a patient’s quality of life and the associated economic burden on the healthcare system.
  • The risk of foot ulceration and limb amputation increases with age and the duration of diabetes.

<

Game da marubucin

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...